Growth Metrics

Edwards Lifesciences (EW) Cash from Operations Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 4.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.30%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 20.35%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 22.35%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -48.14%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.50%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 50.11%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -14.75%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.83%
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 5.31%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -48.14%
Dec 31, 2025 16.82%
Sep 30, 2025 22.79%
Jun 30, 2025 -4.41%
Mar 31, 2025 -1.49%
Dec 31, 2024 -32.79%
Sep 30, 2024 -12.87%
Jun 30, 2024 -10.95%
Mar 31, 2024 -29.62%
Dec 31, 2023 -30.09%
Sep 30, 2023 23.95%
Jun 30, 2023 -47.43%
Mar 31, 2023 14.89%
Dec 31, 2022 -11.13%
Sep 30, 2022 -10.84%
Jun 30, 2022 -0.89%
Mar 31, 2022 480.42%
Dec 31, 2021 8.45%
Sep 30, 2021 15.83%
Jun 30, 2021 55.40%
Mar 31, 2021 25.70%
Dec 31, 2020 3.19%
Sep 30, 2020 -11.41%
Jun 30, 2020 5.37%
Mar 31, 2020 17.31%
Dec 31, 2019 26.07%
Sep 30, 2019 28.54%
Jun 30, 2019 21.49%
Mar 31, 2019 -75.90%
Dec 31, 2018 41.31%
Sep 30, 2018 19.12%
Jun 30, 2018 -6.24%
Mar 31, 2018 27.32%
Dec 31, 2017 57.47%
Sep 30, 2017 194.24%
Jun 30, 2017 -36.66%
Mar 31, 2017 -2.61%
Dec 31, 2016 21.80%
Sep 30, 2016 15.92%
Jun 30, 2016 14.10%
Mar 31, 2016 1.94%
Dec 31, 2015 -3.27%
Sep 30, 2015 15.54%
Jun 30, 2015 5.03%
Mar 31, 2015 63.71%
Dec 31, 2014 -0.07%
Sep 30, 2014 -52.72%
Jun 30, 2014 109.59%
Mar 31, 2014 110.46%
Dec 31, 2013 5.79%
Sep 30, 2013 11.10%
Jun 30, 2013 38.71%
Mar 31, 2013 98.12%
Dec 31, 2012 20.29%
Sep 30, 2012 22.46%